CRH Medical Corp (TSE:CRH) had its price objective increased by Royal Bank Of Canada from C$7.00 to C$8.50 in a report released on Monday morning, StockTargetPrices.com reports. They currently have an outperform rating on the stock.
A number of other brokerages have also issued reports on CRH. Bloom Burton reiterated a buy rating on shares of CRH Medical Corp in a research note on Friday, October 28th. RBC Capital Markets set a C$6.50 target price on shares of CRH Medical Corp and gave the stock an outperform rating in a research note on Thursday, October 6th. Finally, CIBC restated an outperform rating on shares of CRH Medical Corp in a research note on Tuesday, September 13th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus price target of C$7.57.
Shares of CRH Medical Corp (TSE:CRH) opened at 7.01 on Monday. The firm has a market capitalization of $507.01 million and a PE ratio of 71.53. The firm’s 50-day moving average is $6.78 and its 200 day moving average is $5.30. CRH Medical Corp has a 52 week low of $2.98 and a 52 week high of $8.48.